Table 4.
Timing of FBRA administration for suppressing the infiltration of inflammatory cells.
| Treatment Period | No. of Gelatin Sponge-Infiltrated Cells (× 104) a | ||
|---|---|---|---|
| None | 5% FBRA | 10% FBRA | |
| Day −2–5 | 215 ± 15 | 146 ± 21 b | 134 ± 21 b |
| Day 0–1 | 212 ± 35 | 200 ± 14 | 204 ± 19 |
| Day 0–3 | 261 ± 16 | 244 ± 31 | 245 ± 18 |
| Day 0–5 | 202 ± 30 | 215 ± 60 | 230 ± 30 |
| Day −1–0 | 233 ± 25 | 227 ± 26 | 218 ± 15 |
| Day −3–0 | 277 ± 15 | 145 ± 6 b | 140 ± 16 b |
| Day −5–0 | 238 ± 26 | 138 ± 32 b | 152 ± 27 b |
a Five days after implantation of gelatin sponge, sponge-infiltrated cells were collected and counted; b p < 0.01 vs. basal diet-administered mice. Data represent the results of at least two independent experiments.